Efficacy and Safety of Metformin on Clinical and Metabolic Patterns in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis

    December 2011
    Carmen Bouza, Marta Ruiz López, Raimundo Alcazar-Alcazar, Teresa López‐Cuadrado
    TLDR Metformin helps improve symptoms and reduce health risks in PCOS patients.
    The document reviewed the efficacy and safety of metformin in improving clinical, metabolic, and hormonal parameters in patients with Polycystic Ovary Syndrome (PCOS). It aimed to assess whether metformin could reduce the risk of developing diabetes mellitus, metabolic syndrome, and cardiovascular disease. The systematic review and meta-analysis concluded that metformin was effective in improving these parameters in PCOS patients, suggesting a potential benefit in reducing associated health risks. However, as the document was from 2011, the findings might be outdated.
    Discuss this study in the Community →